Ottawa plant to make artificial hearts CMAJ 1997;157:361 © 1997 Canadian Medical Association WorldHeart, the Ottawa company that's in a race to produce the world's first totally implantable artificial heart, is opening a plant in Ottawa to produce its HeartSaver ventricular assist device for use in preclinical trials and then in patients experiencing heart failure (see CMAJ 1997;157:128 [full text]). The plant, which should be fully operational in November, will employ 50 workers. Research and development work will be done at the University of Ottawa Heart Institute and the new facility. "We expect to have the first product from the pilot plant by year's end," said Dr. Tofy Mussivand, WorldHeart's president. The heart institute's Cardiovascular Devices Division has already spent 10 years and $30 million developing a ventricular assist device. Send a letter to the editor responding to this article Envoyez une lettre à la rédaction au sujet de cet article | CMAJ August 15, 1997 (vol 157, no 4) / JAMC le 15 août 1997 (vol 157, no 4) |